Inflammasomes and host defenses against bacterial infections

Current Opinion in Microbiology

Volumn 16, Issue 1, 2013, Pages 23-31

  Vladimer, Gregory I ^a   Marty Roix, Robyn ^a   Ghosh, Shubhendu ^a   Weng, Dan ^a   Lien, Egil ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BACTERIAL RNA; CARRIER PROTEINS AND BINDING PROTEINS; CASPASE 11; CASPASE 8; CATHEPSIN B; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA; MITOCHONDRIAL DNA; NEURONAL APOPTOSIS INHIBITORY PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROTEIN KINASE C BETA; PROTEIN KINASE R; PROTEIN NLRP12; PROTEIN NLRP1B; PROTEIN NLRP6; PROTEIN NLRP7; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ASBESTOSIS; ATHEROSCLEROSIS; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; CARBOXY TERMINAL SEQUENCE; CHLAMYDOPHILA PNEUMONIAE; CHROMOBACTERIUM VIOLACEUM; CITROBACTER RODENTIUM; ENZYME ACTIVATION; ESCHERICHIA COLI; HOST RESISTANCE; HUMAN; INFLAMMATION; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; MITOCHONDRION; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; SILICOSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; TREPONEMA DENTICOLA; VIBRIO CHOLERAE; YERSINIA PESTIS;

ANIMALS; BACTERIAL INFECTIONS; HUMANS; INFLAMMASOMES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 84875813739     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2012.11.008     Document Type: Review

References (68)

1. Franchi L., Muñoz-Planillo R., Nuñez G. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 2012, 13:325-332.
2. Davis B.K., Wen H., Ting J.P.-Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011, 29:707-735.
3. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., Fernandes-Alnemri T., Wu J., Monks B.G., Fitzgerald K.A., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009, 183:787-791.
4. Broz P., Ruby T., Belhocine K., Bouley D.M., Kayagaki N., Dixit V.M., Monack D.M. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 2012, 10.1038/nature11419.
5. Rathinam V.A.K., Vanaja S.K., Waggoner L., Sokolovska A., Becker C., Stuart L.M., Leong J.M., Fitzgerald K.A. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell 2012, 150:606-619.
6. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A.B., Opitz B., van der Meer J.H.M., van de Veerdonk F.L., Ferwerda G., Heinhuis B., Devesa I., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
7. Rathinam V.A.K., Vanaja S.K., Fitzgerald K.A. Regulation of inflammasome signaling. Nat Immunol 2012, 13:333-342.
8. Miao E.A., Rajan J.V., Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011, 243:206-214.
9. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G., Schnurr M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010, 464:1357-1361.
10. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 2007, 14:1583-1589.
11. Franchi L., Kanneganti T.-D., Dubyak G.R., Núñez G. Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 2007, 282:18810-18818.
12. Costa A., Gupta R., Signorino G., Malara A., Cardile F., Biondo C., Midiri A., Galbo R., Trieu-Cuot P., Papasergi S., et al. Activation of the NLRP3 inflammasome by group B streptococci. J Immunol 2012, 188:1953-1960.
13. Sander L.E., Davis M.J., Boekschoten M.V., Amsen D., Dascher C.C., Ryffel B., Swanson J.A., Müller M., Blander J.M. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. Nature 2011, 474:385-389.
14. Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2009, 11:136-140.
15. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.
16. Shimada K., Crother T.R., Karlin J., Dagvadorj J., Chiba N., Chen S., Ramanujan V.K., Wolf A.J., Vergnes L., Ojcius D.M., et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012, 36:401-414.
17. Beal M.F. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci 2003, 991:120-131.
18. Shenoy A.R., Wellington D.A., Kumar P., Kassa H., Booth C.J., Cresswell P., MacMicking J.D. GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 2012, 336:481-485.
19. Lu B., Nakamura T., Inouye K., Li J., Tang Y., Lundbäck P., Valdes-Ferrer S.I., Olofsson P.S., Kalb T., Roth J., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012, 488:670-674.
20. Vyleta M.L., Wong J., Magun B.E. Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome. PLoS ONE 2012, 7:e36044.
21. Miao E.A., Ernst R.K., Dors M., Mao D.P., Aderem A. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci U S A 2008, 105:2562-2567.
22. Zhao Y., Yang J., Shi J., Gong Y.-N., Lu Q., Xu H., Liu L., Shao F. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 2011, 477:596-600.
23. Miao E.A., Mao D.P., Yudkovsky N., Bonneau R., Lorang C.G., Warren S.E., Leaf I.A., Aderem A. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A 2010, 107:3076-3080.
24. Brodsky I.E., Palm N.W., Sadanand S., Ryndak M.B., Sutterwala F.S., Flavell R.A., Bliska J.B., Medzhitov R. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 2010, 7:376-387.
25. Warren S.E., Mao D.P., Rodriguez A.E., Miao E.A., Aderem A. Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol 2008, 180:7558-7564.
26. Kofoed E.M., Vance R.E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011, 477:592-595.
27. Moltke von J., Trinidad N.J., Moayeri M., Kintzer A.F., Wang S.B., van Rooijen N., Brown C.R., Krantz B.A., Leppla S.H., Gronert K., et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 2012, 10.1038/nature11351.
28. Franchi L., Kamada N., Nakamura Y., Burberry A., Kuffa P., Suzuki S., Shaw M.H., Kim Y.-G., Nuñez G. NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat Immunol 2012, 13:449-456.
29. Ayres J.S., Trinidad N.J., Vance R.E. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 2012, 10.1038/nm.2729.
30. Qu Y., Misaghi S., Izrael-Tomasevic A., Newton K., Gilmour L.L., Lamkanfi M., Louie S., Kayagaki N., Liu J., Kömüves L., et al. Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 2012, 10.1038/nature11429.
31. Akhter A., Gavrilin M.A., Frantz L., Washington S., Ditty C., Limoli D., Day C., Sarkar A., Newland C., Butchar J., et al. Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. PLoS Pathog 2009, 5:e1000361.
32. Miao E.A., Leaf I.A., Treuting P.M., Mao D.P., Dors M., Sarkar A., Warren S.E., Wewers M.D., Aderem A. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010, 11:1136-1142.
33. Broz P., Newton K., Lamkanfi M., Mariathasan S., Dixit V.M., Monack D.M. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 2010, 207:1745-1755.
34. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458:514-518.
35. Fernandes-Alnemri T., Yu J.-W., Juliana C., Solorzano L., Kang S., Wu J., Datta P., McCormick M., Huang L., McDermott E., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010, 11:385-393.
36. Rathinam V.A.K., Jiang Z., Waggoner S.N., Sharma S., Cole L.E., Waggoner L., Vanaja S.K., Monks B.G., Ganesan S., Latz E., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010, 11:395-402.
37. Jones J.W., Kayagaki N., Broz P., Henry T., Newton K., O'Rourke K., Chan S., Dong J., Qu Y., Roose-Girma M., et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A 2010, 107:9771-9776.
38. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002, 10:417-426.
39. Bruey J.-M., Bruey-Sedano N., Luciano F., Zhai D., Balpai R., Xu C., Kress C.L., Bailly-Maitre B., Li X., Osterman A., et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129:45-56.
40. Terra J.K., Cote C.K., France B., Jenkins A.L., Bozue J.A., Welkos S.L., LeVine S.M., Bradley K.A. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol 2009, 184:17-20.
41. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
42. Anand P.K., Malireddi R.K.S., Lukens J.R., Vogel P., Bertin J., Lamkanfi M., Kanneganti T.-D. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 2012, 488:389-393.
43. Chen G.Y., Liu M., Wang F., Bertin J., Nuñez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 2011, 186:7187-7194.
44. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Thaiss C.A., Kau A.L., Eisenbarth S.C., Jurczak M.J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
45. Wang L., Manji G.A., Grenier J.M., Al-Garawi A., Merriam S., Lora J.M., Geddes B.J., Briskin M., DiStefano P.S., Bertin J. PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing. J Biol Chem 2002, 277:29874-29880.
46. Vladimer G., Weng D., Paquette S.W.M., Vanaja S.K., Rathinam V.A.K., Aune M.H., Conlon J.E., Burbage J.J., Proulx M.K., Liu Q., et al. The NLRP12 inflammasome recognizes Yersinia pestis. Immunity 2012, 37:96-107.
47. Allen I.C., Wilson J.E., Schneider M., Lich J.D., Roberts R.A., Arthur J.C., Woodford R-MT, Davis B.K., Uronis J.M., Herfarth H.H., et al. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 2012, 36:742-754.
48. Zaki M.H., Vogel P., Malireddi R.K.S., Body-Malapel M., Anand P.K., Bertin J., Green D.R., Lamkanfi M., Kanneganti T.-D. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell 2011, 20:649-660.
49. Arthur J.C., Lich J.D., Ye Z., Allen I.C., Gris D., Wilson J.E., Schneider M., Roney K.E., O'Connor B.P., Moore C.B., et al. Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 2010, 185:4515-4519.
50. Khare S., Dorfleutner A., Bryan N.B., Yun C., Radian A.D., de Almeida L., Rojanasakul Y., Stehlik C. An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 2012, 36:464-476.
51. Meissner T.B., Li A., Biswas A., Lee K.-H., Liu Y.-J., Bayir E., Iliopoulos D., van den Elsen P.J., Kobayashi K.S. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc Natl Acad Sci U S A 2010, 107:13794-13799.
52. Davis B.K., Roberts R.A., Huang M.T., Willingham S.B., Conti B.J., Brickey W.J., Barker B.R., Kwan M., Taxman D.J., Accavitti-Loper M.-A. Cutting edge: NLRC5-dependent activation of the inflammasome. J Immunol 2011, 186:1333-1337.
53. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
54. Vince J.E., Wong W.W.-L., Gentle I., Lawlor K.E., Allam R., O'Reilly L., Mason K., Gross O., Ma S., Guarda G., et al. Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. Immunity 2012, 36:215-227.
55. Labbé K., McIntire C.R., Doiron K., Leblanc P.M., Saleh M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011, 35:897-907.
56. Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B.H. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat Immunol 2012, 13:246-254.
57. Kim S., Bauernfeind F., Ablasser A., Hartmann G., Fitzgerald K.A., Latz E., Hornung V. Listeria monocytogenes is sensed by the NLRP3 and AIM2 inflammasome. Eur J Immunol 2010, 40:1545-1551.
58. Ali S.R., Timmer A.M., Bilgrami S., Park E.J., Eckmann L., Nizet V., Karin M. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 2011, 35:34-44.
59. Kovarova M., Hesker P.R., Jania L., Nguyen M., Snouwaert J.N., Xiang Z., Lommatzsch S.E., Huang M.T., Ting J.P.-Y., Koller B.H. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J Immunol 2012, 189:2006-2016.
60. Ceballos-Olvera I., Sahoo M., Miller M.A., Del Barrio L., Re F. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog 2011, 7:e1002452.
61. He X., Mekasha S., Mavrogiorgos N., Fitzgerald K.A., Lien E., Ingalls R.R. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 2010, 184:5743-5754.
62. Saiga H., Kitada S., Shimada Y., Kamiyama N., Okuyama M., Makino M., Yamamoto M., Takeda K. Critical role of AIM2 in Mycobacterium tuberculosis infection. Int Immunol 2012, 10.1093/intimm/dxs062.
63. Mishra B.B., Moura-Alves P., Sonawane A., Hacohen N., Griffiths G., Moita L.F., Anes E. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 2010, 10.1111/j.1462-5822.2010.01450.x.
64. Kebaier C., Chamberland R.R., Allen I.C., Gao X., Broglie P.M., Hall J.D., Jania C., Doerschuk C.M., Tilley S.L., Duncan J.A. Staphylococcus aureus - hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis 2012, 205:807-817.
65. McNeela E.A., Burke A., Neill D.R., Baxter C., Fernandes V.E., Ferreira D., Smeaton S., El-Rachkidy R., McLoughlin R.M., Mori A., et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 2010, 6:e1001191.
66. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Nuñez G., et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol 2010, 184:3326-3330.
67. Jun H.-K., Lee S.-H., Lee H.-R., Choi B.-K. Integrin α5β1 activates the NLRP3 inflammasome by direct interaction with a bacterial surface protein. Immunity 2012, 36:755-768.
68. Zheng Y., Lilo S., Brodsky I.E., Zhang Y., Medzhitov R., Marcu K.B., Bliska JB A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog 2011, 7:e1002026.